- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02141750
THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES (RENASICA_III)
May 15, 2014 updated by: Third National Registry of Acute Coronary Syndromes
The Registry pretends to identify stratification, diagnosis and treatment approaches in patients with Acute Coronary Syndrome (ACS) in community hospitals with tertiary hospitals to optimize resources and identify strategies to improve health care quality through the creation of clinical guidelines that serve for unify management and treatment methods with adherence to international guidelines which include suggestions for treatment and medication.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
8296
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
It will include patients older than 18 years with ACS final diagnosis and objective evidence of atherosclerotic coronary disease.
Patients will be identified in the emergency department, coronary care units, intensive care units, hospital and hemodynamic laboratories
Description
Inclusion Criteria:
all patients with suspected ACS and will analyze risk factors, chest pain and electrocardiographic characteristics.
Exclusion Criteria:
Patients with secondary ischemia (anaemia, pulmonary thromboembolism, myocarditis) and type II infarction.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of patients with complications after presenting ACS
Time Frame: up to one year
|
The main objective will be to know the evolution of ACS in third and second level hospitals with a monitoring at a minimum of one year for each patient.
|
up to one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
November 1, 2013
Study Registration Dates
First Submitted
May 15, 2014
First Submitted That Met QC Criteria
May 15, 2014
First Posted (Estimate)
May 19, 2014
Study Record Updates
Last Update Posted (Estimate)
May 19, 2014
Last Update Submitted That Met QC Criteria
May 15, 2014
Last Verified
May 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RENASICA III
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndromes
-
Virginia Commonwealth UniversityBracco Diagnostics, IncTerminatedCoronary Artery Disease | Acute Coronary SyndromesUnited States
-
Lene HolmvangCompletedCoronary Artery Disease | Percutaneous Coronary Intervention | Acute Coronary SyndromesDenmark
-
Shanghai Zhongshan HospitalActive, not recruiting
-
AstraZenecaCompletedAcute Coronary SyndromesKorea, Republic of
-
Yaling HanUnknownAcute Coronary SyndromesChina
-
Centre Hospitalier Universitaire de BesanconCompletedAcute Coronary SyndromesFrance
-
Samsung Medical CenterUnknownAcute Coronary SyndromesKorea, Republic of
-
Sahlgrenska University Hospital, SwedenAstraZenecaCompletedAcute Coronary SyndromesSweden
-
Xijing HospitalUnknown
-
Dr. Sanjit S. JollyMcMaster University; Population Health Research InstituteCompleted